Why the study?
Does the process of antihypertensive care (treatment decision, vigor, and compliance) improve diastolic blood pressure outcomes in hypertensive patients?
Does the process of antihypertensive care (treatment decision, vigor, and compliance) improve diastolic blood pressure outcomes in hypertensive patients?
The process of antihypertensive care, specifically the decision to treat, treatment vigor, and patient compliance, is significantly associated with improved diastolic blood pressure outcomes.
No takes yet. Share an insight, caveat, or question.
Should not yet change hypertension care processes; leaves open whether targeting vigor and compliance improves DBP in prospective trials.
Haynes et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: